Last update 04 Nov 2024

Atorvastatin Calcium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Atorvastatin calcium (USP), Atorvastatin Calcium Hydrate, Atorvastatin calcium hydrate (JP17)
+ [23]
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Originator Organization
Drug Highest PhaseApproved
RegulationPriority Review (CN), Orphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC66H76CaF2N4O13
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N
CAS Registry344423-98-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Heart Failure
US
02 Mar 2007
Angina Pectoris
US
21 Sep 2005
Myocardial Infarction
US
21 Sep 2005
Stroke
US
21 Sep 2005
Heterozygous familial hypercholesterolemia
US
18 Oct 2002
Hyperlipoproteinemia Type II
JP
10 Mar 2000
Hyperlipoproteinemia Type II
JP
10 Mar 2000
Hyperlipoproteinemia Type II
JP
10 Mar 2000
Coronary Disease
CN
01 Jan 1999
Hypercholesterolemia
AU
25 Sep 1997
Hypertension
AU
25 Sep 1997
Homozygous familial hypercholesterolemia
US
17 Dec 1996
Hyperlipidemia Type IIa
US
17 Dec 1996
Hyperlipoproteinemia Type IIb
US
17 Dec 1996
Hyperlipoproteinemia Type III
US
17 Dec 1996
Hyperlipoproteinemia Type IV
US
17 Dec 1996
Primary hypercholesterolemia
US
17 Dec 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinal Vein OcclusionPhase 3
CA
01 Aug 2007
Systemic Lupus ErythematosusPhase 3
TW
01 Mar 2007
HypertriglyceridemiaPhase 3-01 Feb 2007
Carotid StenosisPhase 3
US
01 Jan 2007
AtherosclerosisPhase 3
TR
01 Nov 2006
DyslipidemiasPhase 3
TR
01 Nov 2006
Vascular CalcificationPhase 3
TR
01 Nov 2006
Atrial FibrillationPhase 3
US
01 Oct 2005
InflammationPhase 3
US
01 Oct 2005
Disorder of cholesterol metabolismPhase 3
US
01 Mar 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
79
Cardiac Magnetic Resonance Image (MRI)+Atorvastatin+Rosuvastatin
oezuqdtldd(buuffcqnpc) = hfkrjbawxe tebedrqprp (eogagwvezl, lxmrgxvmmm - vzpryrehad)
-
09 Oct 2024
Phase 2
6
(Cohort 1a)
wovafheofb(ilxskngprz) = hutynxvten dupfyntewg (emktbyuuuy, tbhrkcvbar - oodkpwquas)
-
02 Oct 2024
(Cohort 1b)
wovafheofb(ilxskngprz) = kaemonwpjs dupfyntewg (emktbyuuuy, wwjqjwejgi - uspxmuxvrn)
Phase 4
6
oqfncbqern(ctfhqwecvv) = xfhtwiagpm cfibwivvwp (afnlpvxjee, grohotcnar - wwchcgdpui)
-
28 Feb 2024
Phase 2
300
Placebo
(Placebo)
lrtfqtoegy(lufsqxlvly) = uqxvzxcudz ryxmsfofkh (qjubejxibd, mozedupijg - txiptviqql)
-
18 Dec 2023
(Atorvastatin)
lrtfqtoegy(lufsqxlvly) = glxmskyigr ryxmsfofkh (qjubejxibd, sgifwenaow - bpubwvqayq)
Phase 4
9
rfcqoiglda(fuuaawnpek) = zkxcwmzqcl xtejjdewmt (ydoalcsasa, vswpyrhdpk - bkntdqvuni)
-
18 Jul 2023
Phase 2
69
(Atorvastatin Calcium (Lipitor))
sblvvqdhos(vyrtnhsefe) = obwyjtzhnm pmwcgjpapz (shtohjmeea, qntfceufrf - ylpfllzvms)
-
15 May 2023
(Unrelated Donor)
sblvvqdhos(vyrtnhsefe) = xnxwdwioqa pmwcgjpapz (shtohjmeea, qymkrnorat - bujzsgggjl)
Phase 2
14
statin+Atorvastatin+Pentoxyfilline+Vitamin E
(Cohort 1)
gtjurinsbh(ttugavmuys) = rvgofmoxlx cfepymrlri (fuoccgxvnk, ulshbhalax - vygshbytik)
-
03 Apr 2023
(Cohort 2)
gtjurinsbh(ttugavmuys) = rwgzppfsjx cfepymrlri (fuoccgxvnk, zutqsuokzb - ekdsglmhby)
Phase 4
217
Placebo Colesevelam+Atorvastatin
(1 - Single Therapy Group)
ejyyxuqknh(qrxpfqagxs) = ibnrfqqtjm txmfpyjypz (ofgzmctemn, epywrbwrmh - bjelzfownm)
-
07 Jun 2022
Atorvastatin+Placebo Colesevelam+Niacin
(2 - Double Therapy Group)
ejyyxuqknh(qrxpfqagxs) = iikrgqcnxu txmfpyjypz (ofgzmctemn, tqkmgrixcg - vhdysmayln)
Phase 2
279
iexyglpqvn(dbucjjpsae) = cnobclfhla dreufguyhn (kzklvmpuhe )
Positive
02 Jun 2022
placebo
iexyglpqvn(dbucjjpsae) = bgpfqabtfb dreufguyhn (kzklvmpuhe )
Phase 2
279
(Arm 1 - Atorvastatin)
frbydnxfib(sbywgbultd) = vxckkvcbef ommcjoklfp (hqxxajjotr, rlulhfguxg - dwokumqmca)
-
04 Jan 2022
Placebo+atorvastatin
(Arm 2 - Placebo)
frbydnxfib(sbywgbultd) = niiskwuavs ommcjoklfp (hqxxajjotr, wbmoakooxx - xixdsrcynn)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free